Latest news



Pfizer shot gets U.K. green light

Coronavirus Daily

Here's the latest news from the global pandemic.

Green light for Pfizer's shot in the U.K.

The U.K. became the first western country to approve a Covid-19 vaccine, with its regulator clearing Pfizer and BioNTech's shot ahead of decisions in the U.S. and European Union.

The emergency authorization clears the way for the deployment of a vaccine that Pfizer and its German partner have said is 95% effective in preventing illness. The shot will be available in Britain from next week.

"This is going to be one of the biggest civilian projects in history," Health Secretary Matt Hancock said in a radio interview, with 50 hospitals preparing to administer the vaccine and 800,000 doses ready to be delivered from Belgium.

The U.K. had signaled it would move swiftly in approving a vaccine, and doctors across the country were put on standby for a possible rollout. For U.K. Prime Minister Boris Johnson, the rollout may offer some political respite after eight months of criticism over his pandemic strategy, as Britain's death toll nears 60,000.

"We can see the way out, and we can see that by the spring we are going to be through this," Hancock said on Sky News.

But first the government needs to deliver the shots efficiently across the country, and its patchy record on pandemic logistics is one reason often given for why the U.K. has the highest death toll in Europe. In a further complication, a Brexit trade deal has yet to be signed and the end of transitional arrangements risks disrupting supply chains at the turn of the year.

The U.K. still needs other vaccines to reach the finish line in order to immunize enough of its population to end the pandemic. The country has ordered enough doses of the two-shot Pfizer-BioNTech shot for 20 million people, less than one-third of the population.

Find more answers to your questions and what comes next here.—Naomi Kresge and James Paton

Track the vaccine

Covid-19 Vaccinations Are About to Begin

The U.K. said shots can start as early as next week, but more than one vaccine will be needed to beat the pandemic. Other front-runner shots — one from Moderna and the other from AstraZeneca and the University of Oxford — may also be approved soon. Get the latest here.

BioNTech Covid-19 vaccine.

Source: BioNTech SE


What you should read

Covid Revved Up Our Takeout Habit, Left a Mess
Downside to all that meal convenience has been a massive pileup of waste.
Hot Housing: U.K. Shows Uneven Virus Economy
Home prices surge; young people who bore brunt of crisis are priced out.
Herd Immunity Stays Mystery to Sweden's Tegnell
Man behind no-lockdown virus strategy still puzzled by immunity questions.
Japan's New Virus Wave Is Older, More Serious
Japan is adjusting strategies as it enters winter with a vulnerable population.
'Work-From-Home' Means Two Hours More TV
Many viewers keep the sound on while working, researcher Nielsen says.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

Post a comment